- Home
- BTAI vs IZEA Comparison
BTAI vs IZEA Comparison
Compare BTAI & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- IZEA
- Stock Information
- Founded
- BTAI 2017
- IZEA 2006
- Country
- BTAI United States
- IZEA United States
- Employees
- BTAI N/A
- IZEA N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- IZEA Advertising
- Sector
- BTAI Health Care
- IZEA Consumer Discretionary
- Exchange
- BTAI Nasdaq
- IZEA Nasdaq
- Market Cap
- BTAI 52.7M
- IZEA 60.8M
- IPO Year
- BTAI 2018
- IZEA N/A
- Fundamental
- Price
- BTAI $3.01
- IZEA $3.61
- Analyst Decision
- BTAI Buy
- IZEA
- Analyst Count
- BTAI 5
- IZEA 0
- Target Price
- BTAI $32.80
- IZEA N/A
- AVG Volume (30 Days)
- BTAI 5.2M
- IZEA 93.3K
- Earning Date
- BTAI 11-13-2025
- IZEA 11-13-2025
- Dividend Yield
- BTAI N/A
- IZEA N/A
- EPS Growth
- BTAI N/A
- IZEA N/A
- EPS
- BTAI N/A
- IZEA N/A
- Revenue
- BTAI $868,000.00
- IZEA $36,935,906.00
- Revenue This Year
- BTAI N/A
- IZEA $11.15
- Revenue Next Year
- BTAI $614.78
- IZEA $17.64
- P/E Ratio
- BTAI N/A
- IZEA N/A
- Revenue Growth
- BTAI N/A
- IZEA 12.49
- 52 Week Low
- BTAI $1.17
- IZEA $1.68
- 52 Week High
- BTAI $13.28
- IZEA $4.39
- Technical
- Relative Strength Index (RSI)
- BTAI 41.66
- IZEA 46.09
- Support Level
- BTAI $2.86
- IZEA $3.40
- Resistance Level
- BTAI $3.95
- IZEA $3.90
- Average True Range (ATR)
- BTAI 0.34
- IZEA 0.30
- MACD
- BTAI -0.17
- IZEA -0.04
- Stochastic Oscillator
- BTAI 11.89
- IZEA 30.71
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About IZEA IZEA Worldwide Inc.
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.